New $2m gait research centre launched
11 July, 2005 by Ruth BeranFederal treasurer Peter Costello and Dame Elisabeth Murdoch today launched the $2 million Centre for Clinical Research Excellence (CCRE) in Gait Analysis and Rehabilitation at the Royal Children's Hospital, Melbourne.
Perth's OBJ claims progress on 'electronic' drug patch
08 July, 2005 by Helen SchullerDrug delivery company OBJ (ASX:OBJ) claims to have reached an advanced stage in the development of its coin-sized smart drug patch.
GTG boss reflects on 'unusual' license dispute
08 July, 2005 by Graeme O'NeillMutual fatigue, and the peculiar challenges involved in negotiating with New Zealand's research and health-service agencies, were behind the mediated settlement of the Auckland District Health Board's dispute with Melbourne biotech Genetic Technologies (ASX:GTG) over licensing fees for GTG's non-coding DNA gene testing and mapping technology in NZ.
Shoppers will decide on GM: industry
08 July, 2005 by Ruth BeranConsumer perception of genetic modification (GM) has a big impact on research and the products produced by the agricultural biotechnology industry, delegates at a BioMelbourne BioBreakfast have heard.
New Chinese bird flu strain: low risk to Aust
08 July, 2005 by Graeme O'NeillChinese scientists have traced the deaths of around 1500 migratory waterbirds, including geese, gulls and cormorants on isolated Qinghai Lake in western China to a new strain of the lethal H5N1 influenza virus , or 'bird flu'.
Australia-China science collaboration set to increase
08 July, 2005 by Helen SchullerAustralia has cemented its strong relationship in science and technology with China following the signing of two new agreements aimed at enhancing collaboration between the two nations.
Study offers new clues to killer viruses
08 July, 2005 by Graeme O'NeillVirologists have identified the cellular receptor that serves as a portal for infection by deadly bat-borne Henipa viruses, which have caused human deaths in Australia, Malaysia, Singapore and Bangladesh during the past decade.
Biotechnology student resource revamped
08 July, 2005 by Helen SchullerBiotechnology Online, a national education resource aimed at making high-school students more aware of the ethics and scientific principles of biotechnology has been updated and relaunched.
Epitan raises AUD$3.5 million in private placement
07 July, 2005 by Ruth BeranMelbourne's Epitan (ASX:EPT) has raised AUD$3.5 million by way of a private placement, assisted by Mariner Corporate Finance, to institutional investors in Europe and Australia.
Peptech awarded third patent for male dog contraceptive
07 July, 2005 by Helen SchullerPeptech Animal Health, a subsidiary of Peptech (ASX:PTD), has been granted an additional United States patent increasing the intellectual property protection of its peptide-based male dog contraceptive implant Suprelorin.
In brief: GTG, Resonance Health, Sirtex
07 July, 2005 by Ruth BeranGenetic Technologies (ASX:GTG) has settled all of its disputes with the Auckland District Health Board, as the representative of all the New Zealand district health boards plus the New Zealand Blood Service.
New centre to look at approaches to imaging proteins
07 July, 2005 by Helen SchullerA new Centre of Excellence in Coherent X-Ray Science will be developed with an AUD$9 million ARC grant over five years, involving Australian and overseas universities and other organisations.
Big names on grant winners list
06 July, 2005 by Iain ScottSome of the biggest names in Australian science are among the big winners of more than AUD$100 million in National Health and Medical Research Council grants, announced on Wednesday.
Vet Biotech gets green light for horse stem cell therapy
06 July, 2005 by Helen SchullerAustralian animal health company, Vet Biotechnology, has been given the green light to perform equine supply stem cell therapies for tendon and ligament injuries in Australia.
Cryptome, NTRI to team up on brain trauma drugs
06 July, 2005 by Ruth BeranMelbourne-based Cryptome Pharmaceuticals (ASX:CRP) and the National Trauma Research Institute (NTRI), at the Alfred Hospital, have signed an agreement that will accelerate Cryptome's drug discovery platform in neuroinflammation.
